Rating Change
HC Wainwright & Co. analysts downgraded NeuroSense Therapeutics Ltd. Ordinary Shares (NASDAQ:NRSN) from Buy to Neutral on November 02, 2026.
downgradeNASDAQ:NRSN
NeuroSense Therapeutics Ltd. Ordinary Shares (NRSN) Downgraded to Neutral by HC Wainwright & Co.
HC Wainwright & Co. analysts downgraded NeuroSense Therapeutics Ltd.
At publication ·
What changed
NeuroSense Therapeutics Ltd. Ordinary Shares (NASDAQ:NRSN) · downgrade
- Firm
- HC Wainwright & Co.
- Rating
- Buy to Neutral
- Price at event
- $1.43
- Market capitalization
- $21.8M
At a glance
Key takeaways
- HC Wainwright & Co. downgraded NeuroSense Therapeutics (NRSN) from Buy to Neutral on November 2, 2026.
- NRSN trades at $1.43 with a $21.8 million market capitalization and has gained 87.7% over the past 52 weeks.
Market Context
NeuroSense Therapeutics Ltd. Ordinary Shares operates in the Healthcare sector. The stock currently trades at $1.43 with a market capitalization of $21.8M. The stock has gained 87.7% over the past 52 weeks.
Analyst downgrades can weigh on a stock in the short term as institutional investors who follow HC Wainwright & Co.'s research adjust their positions. However, downgrades also sometimes create buying opportunities if the market overreacts to the rating change. The reasoning behind the downgrade matters more than the rating itself.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for NeuroSense Therapeutics Ltd. Ordinary Shares
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Nov 02, 2026 | HC Wainwright & Co. | Neutral | N/A |
| Sep 28, 2026 | HC Wainwright & Co. | Buy | N/A |
| Sep 03, 2026 | HC Wainwright & Co. | Buy | N/A |
| Apr 08, 2026 | D. Boral Capital | Buy | N/A |
| Mar 25, 2026 | D. Boral Capital | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View NRSN Stock Page
Frequently Asked Questions
What does the Neutral rating mean for NRSN?
A rating of Neutral from HC Wainwright & Co. reflects the analyst's outlook on NeuroSense Therapeutics Ltd. Ordinary Shares (NASDAQ:NRSN). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the NRSN forecast page.